Last updated on April 2017

Evaluation of the CytoRADx System as a Biodosimeter for Special Human Populations


Brief description of study

Evaluation of the CytoRADx System as a Biodosimeter for Special Human Populations

Detailed Study Description

This study is designed to evaluate whether the dose results produced by the CytoRADx system are affected by immunocompromise (HIV), young age and by medical conditions that would accompany detonation of an IND or widespread radiation exposure; such as burns, sepsis, and trauma

.

Clinical Study Identifier: TX148877

Contact Investigators or Research Sites near you

Start Over

Research Center

Columbus Regional Research Institute
Columbus, GA USA
  Connect »